Vir Biotech gets U.S. funding for flu-prevention antibody
(Reuters) – Vir Biotechnology Inc said on Tuesday it had received $55 million in funding from the U.S. government to support its influenza-focused antibody drug that is expected to enter mid-stage trials…
